Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib

Detalles Bibliográficos
Autores principales: Gower, Arjan, Golestany, Barry, Gong, Jun, Singhi, Aatur D., Hendifar, Andrew Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446504/
https://www.ncbi.nlm.nih.gov/pubmed/32923899
http://dx.doi.org/10.1200/PO.19.00365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446504/
https://www.ncbi.nlm.nih.gov/pubmed/32923899
http://dx.doi.org/10.1200/PO.19.00365

Ejemplares similares